{"id":"W4241968959","doi":"10.1016/j.jval.2014.08.2267","title":"Cost-Effectiveness of Ofatumumab Plus Chlorambucil in First Line Chronic Lymphocytic Leukemia in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Ofatumumab; Chlorambucil; Medicine; Fludarabine; Population; Time horizon; Quality-adjusted life year; Cost effectiveness; Chronic lymphocytic leukemia; Internal medicine; Oncology; Leukemia; Chemotherapy; Mathematics; Risk analysis (engineering); Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009190864,0.0004420113,0.001068825,0.001035003,0.001271872,0.002149439,0.001515486,0.0008677883,0.003595887],"category_scores_gemma":[0.006929875,0.0002973826,0.001814209,0.002318217,0.0008029332,0.0005905832,0.0007865739,0.001411955,0.0001015519],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.1247148,"about_ca_system_score_gemma":0.1138687,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9889609,"about_ca_topic_score_gemma":0.9933164,"domain_scores_codex":[0.9982929,0.0003880695,0.0001106635,0.000132738,0.0004251713,0.0006504783],"domain_scores_gemma":[0.9959487,0.000686481,0.0005589693,0.00004580661,0.001139499,0.00162049],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.06348305,0.002440056,0.5569283,0.004442267,0.005515554,0.001484286,0.00100638,0.05494908,0.001553017,0.009176131,0.04241861,0.2566033],"study_design_scores_gemma":[0.01607613,0.005523445,0.8928125,0.002437344,0.008020569,0.001137975,0.004089886,0.04404542,0.00112773,0.001884092,0.02256767,0.0002774243],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9557534,0.01997874,0.0002170331,0.009217007,0.0002331587,0.0002996954,0.005802379,0.00003633717,0.008462226],"genre_scores_gemma":[0.9929994,0.004119205,0.0002831825,0.0004793999,0.00004515611,0.00003380563,0.001037127,0.000007020682,0.0009956734],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1247148,"threshold_uncertainty_score":0.9048732,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05877112671093143,"score_gpt":0.329355149885676,"score_spread":0.2705840231747446,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}